WET AGE RELATED MACULAR DEGENERATION
Clinical trials for WET AGE RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Shot gene therapy aims to ease burden of frequent eye injections
Disease control Not yet recruitingThis early-phase trial tests a gene therapy called EXG202 for wet age-related macular degeneration (nAMD). The goal is to see if a single injection into the eye can safely deliver a protein that blocks abnormal blood vessel growth, potentially reducing the need for repeated anti-…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Jiayin Biotech Ltd • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Elderly AMD patients to test Easy-to-Use home vision tracker
Knowledge-focused Not yet recruitingThis study looks at whether elderly patients with wet age-related macular degeneration (AMD) are willing to use a new web-based system that tracks eye movements to monitor vision at home. About 30 people aged 55 to 99 will try the system and answer questions about how easy it is …
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC